427.59
                                            
                                Überblick
                                Nachrichten
                                Preisverlauf
                                    Optionskette
                                Financials
                                    Warum fällt MDGL?
                                Forum
                                Prognose
                                    Aktiensplit
                        
                        Madrigal Pharmaceuticals Inc Aktie (MDGL) Neueste Nachrichten
Madrigal Pharmaceuticals (NASDAQ:MDGL) Upgraded by Bank of America to Neutral Rating - MarketBeat
Madrigal Pharmaceuticals Q3 Net Loss Widens, Revenue Rises - MarketScreener
Madrigal Pharmaceuticals Q3 2025 Earnings: EPS Misses, Revenue S - GuruFocus
Madrigal Pharmaceuticals (MDGL) Reports Strong Q3 Revenue Boost - GuruFocus
Madrigal: Q3 Earnings Snapshot - San Francisco Chronicle
Madrigal Pharmaceuticals (NASDAQ: MDGL) reports $287.3M Q3 sales, up from $62.2M - Stock Titan
How Madrigal Pharmaceuticals Inc. (YDO1) stock performs in volatility spikes2025 Market WrapUp & Daily Price Action Insights - newser.com
Visual analytics tools that track Madrigal Pharmaceuticals Inc. performanceJuly 2025 Setups & Daily Stock Trend Watchlist - newser.com
Can Madrigal Pharmaceuticals Inc. stock beat market expectations this quarterOptions Play & Weekly Chart Analysis and Guides - newser.com
How to escape a deep drawdown in Madrigal Pharmaceuticals Inc.Portfolio Gains Summary & Safe Entry Momentum Stock Tips - newser.com
Why analysts recommend Madrigal Pharmaceuticals Inc. (YDO1) stockDay Trade & Weekly Return Optimization Plans - newser.com
Is Madrigal Pharmaceuticals Inc. trending in predictive chart modelsJuly 2025 Movers & Technical Pattern Based Buy Signals - newser.com
Chart based exit strategy for Madrigal Pharmaceuticals Inc.July 2025 Snapshot & Daily Profit Maximizing Tips - newser.com
Madrigal Pharmaceuticals (MDGL) Upgraded to Neutral by BofA on R - GuruFocus
Madrigal Pharmaceuticals upgraded at BofA on Rezdiffra uptake - Seeking Alpha
Why Madrigal Pharmaceuticals Inc. (YDO1) stock signals breakout potential2025 Technical Patterns & Safe Capital Preservation Plans - newser.com
MDGL: B of A Securities Upgrades Madrigal Pharmaceuticals to Neutral | MDGL Stock News - GuruFocus
Madrigal Pharmaceuticals stock rating upgraded by BofA on strong launch - Investing.com Canada
BofA Upgrades Madrigal Pharmaceuticals to Neutral From Underperform, Price Target is $445 - MarketScreener
How Madrigal Pharmaceuticals Inc. stock reacts to global recession fearsJuly 2025 Final Week & Reliable Momentum Entry Alerts - newser.com
Statistical indicators supporting Madrigal Pharmaceuticals Inc.’s strengthEarnings Risk Summary & Free High Return Stock Watch Alerts - newser.com
Madrigal Pharmaceuticals Inc. stock trendline breakdownWeekly Risk Summary & Weekly Market Pulse Alerts - newser.com
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Will Madrigal Pharmaceuticals Inc. stock gain from lower inflationJuly 2025 News Drivers & Daily Profit Maximizing Tips - newser.com
Can Madrigal Pharmaceuticals Inc. stock hit record highs againJuly 2025 EndofMonth & Pattern Based Trade Signal System - newser.com
How strong is Madrigal Pharmaceuticals Inc. (YDO1) stock earnings growthJuly 2025 Institutional & Weekly High Potential Stock Alerts - newser.com
How to integrate Madrigal Pharmaceuticals Inc. into portfolio analysis tools2025 Price Targets & AI Forecast Swing Trade Picks - newser.com
Madrigal Pharmaceuticals Inc. stock chart pattern explained2025 Technical Patterns & Risk Managed Investment Signals - newser.com
Will Madrigal Pharmaceuticals Inc. (YDO1) stock keep raising dividendsJuly 2025 Setups & Accurate Trade Setup Notifications - newser.com
Research Analysts Offer Predictions for MDGL FY2025 Earnings - MarketBeat
Is it too late to sell Madrigal Pharmaceuticals Inc.July 2025 Analyst Calls & Intraday High Probability Setup Alerts - newser.com
Madrigal Pharmaceuticals, Inc. (MDGL) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
A Look at Madrigal Pharmaceuticals (MDGL) Valuation Following New Rezdiffra Data to Be Presented at AASLD 2025 - Sahm
What analysts say about Madrigal Pharmaceuticals Inc YDO1 stockExit Strategy Tips & Turn Market Volatility into Wealth - earlytimes.in
Madrigal Pharmaceuticals to Report Third-Quarter 2025 Results on November 4 - MSN
Emerald Mutual Fund Advisers Trust Boosts Stock Position in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
Using RSI to spot recovery in Madrigal Pharmaceuticals Inc.Market Performance Summary & Risk Managed Trade Strategies - newser.com
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):